(Q53945420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Characterisation of new efaroxan derivatives for use in purification of imidazoline-binding sites (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

Chan SL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Pallett AL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Clews J

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Ramsden CA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Chapman JC

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Kane C

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Dunne MJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

67-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

Effects of alpha-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Role of alpha 2-adrenoceptors and imidazoline-binding sites in the control of insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Stimulation of insulin secretion by the imidazoline α2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

.alpha.-Adrenoceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on .alpha.-adrenoreceptor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I1 and I2 binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Block of ATP-regulated potassium channels by phentolamine and other α-adrenoceptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Potassium channels, imidazolines, and insulin-secreting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

'Seeing through a glass darkly': casting light on imidazoline 'I' sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

High-conductance K+ channel in pancreatic islet cells can be activated and inactivated by internal calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Pentitols and insulin release by isolated rat islets of Langerhans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Characterization of the imidazoline binding site involved in regulation of insulin secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Phentolamine block of KATP channels is mediated by Kir6.2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Imidazoline receptors and their endogenous ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Effects of imidazoline compounds on cytoplasmic Ca2+ concentration and ATP-sensitive K+ channels in pancreatic B-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Augmentation of glucose induced insulin secretion by pertussis vaccine, phentolamine and benextramine: involvement of mechanisms additional to prevention of the inhibitory actions of catecholamines in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

Measurement of protein using bicinchoninic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900466-X

10.1016/S0014-2999(98)00466-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9754940%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference